GeoVax Announces 100% Protection Data from Marburg Virus Vaccine Study

NEXT STORY
Salarius Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell
PREV STORY
Ziopharm Oncology Announces $45 Million Warrant Exercise by Existing Shareholders in a Private Placement
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Neovacs Announces FDA Acceptance of a New IND to Expand in U.S. IFNalpha Kinoid Clinical Development Program in Dermatomyositis

PRESS RELEASE  ·    PRESS RELEASE   ·   PRESS RELEASE Neovacs Announces FDA Acceptance of a ...

author_avatar
NASDAQ Market News

InflaRx Announces Positive Topline Results for Vilobelimab from the U.S. Phase II ANCA-Associated Vasculitis IXPLORE Study

author_avatar
NASDAQ Market News

Cytovia and Cellectis Expand Their TALEN® Gene-Edited iNK Partnership to Enable Broader Collaboration in China

author_avatar
NASDAQ Market News